GlassScriptPhysician profile
Ryan Shea Fitzgerald
NPI 1346689411
$1,296.11
in general payments reported to CMS, 2019-2025
17 companies · $15.03 in 2025
The $15.03 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,198 · 2020: $12.13 · 2021: $26.46 · 2023: $44.61 · 2025: $15.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $159.92 | 2019 | |
| Amgen INC. | $156.65 | 2019 | |
| Pfizer INC. | $130.51 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.31 | 2019 | |
| Lilly USA, LLC | $129.07 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $110.92 | 2019 | |
| Amarin Pharma, INC. | $80.30 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $66.08 | 2019-2023 | Rexulti |
| Glaxosmithkline, LLC. | $61.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $56.35 | 2019 | |
| Astellas Pharma US INC | $49.67 | 2019 | |
| Allergan, INC. | $44.86 | 2019 | |
| Novo Nordisk INC | $42.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $36.79 | 2019 | |
| Exact Sciences Corporation | $15.03 | 2025 | The Cologuard Plus Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.15 | 2019 | |
| Cranial Technologies, INC | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Fitzgerald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.